Granzyme B: Pro-apoptotic, antiviral and antitumor functions

Current Opinion in Immunology

Volumn 15, Issue 5, 2003, Pages 533-543

  Trapani, Joseph A ^a   Sutton, Vivien R ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; DNA FRAGMENT; DNA TOPOISOMERASE; ENZYME INHIBITOR; FAS LIGAND; GLUTAMATE RECEPTOR; GRANZYME B; LAMIN B; LEUKEMIA INHIBITORY FACTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PERFORIN; PROTEIN BCL 2; PROTEOGLYCAN; RECOMBINANT ENZYME; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CARCINOGENICITY; CARTILAGE; CELL DIFFERENTIATION; CELL PROTECTION; CYTOMEGALOVIRUS; CYTOSOL; ENZYME SUBSTRATE; EXPERIMENTAL MOUSE; HUMAN; IMMUNITY; IMMUNOPATHOLOGY; MITOCHONDRIAL RESPIRATION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL; TRYPANOSOMA CRUZI; VIRUS INFECTION;

EID: 0141629530     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(03)00107-9     Document Type: Review

References (89)

1. Barry M., Bleackley R.C. Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol. 2:2002;401-409.
2. Trapani J.A., Smyth M.J. Functional significance of the perforin/ granzyme cell death pathway. Nat Rev Immunol. 2:2002;735-747.
3. Shi L., Kam C.M., Powers J.C., Aebersold R., Greenberg A.H. Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J Exp Med. 176:1992;1521-1529.
4. Kagi D., Ledermann B., Burki K., Seiler P., Odermatt B., Olsen K.J., Podack E.R., Zinkernagel R.M., Hengartner H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369:1994;31-37.
5. Smyth M.J., Thia K.Y., Street S.E., MacGregor D., Godfrey D.I., Trapani J.A. Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma. J Exp Med. 192:2000;755-760.
6. Heusel J.W., Wesselschmidt R.L., Shresta S., Russell J.H., Ley T.J. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell. 76:1994;977-987.
7. Andrade F., Bull H.G., Thornberry N.A., Ketner G.W., Casciola-Rosen L.A., Rosen A. Adenovirus L4-100K assembly protein is a granzyme B substrate that potently inhibits granzyme B-mediated cell death. Immunity. 14:2001;751-761.
8. Odake S., Kam C.M., Narasimhan L., Poe M., Blake J.T., Krahenbuhl O., Tschopp J., Powers J.C. Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins. Biochemistry. 30:1991;2217-2227.
9. Metkar S.S., Wang B., Aguilar-Santelises M., Raja S.M., Uhlin-Hansen L., Podack E., Trapani J.A., Froelich C.J. Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane pore formation. Immunity. 16:2002;417-428 This paper makes two intriguing observations: firstly that a proportion of cells exposed to perforin and granzyme B undergo cell death without overt plasma membrane pore formation; secondly, that granzyme B and perforin may be co-delivered to a target cell on a scaffold of cytotoxic granule-derived proteoglycan to which they are held by electrostatic forces.
10. Raja S.M., Wang B., Dantuluri M., Desai U.R., Demeler B., Spiegel K., Metkar S.S., Froelich C.J. Cytotoxic cell granule-mediated apoptosis. Characterization of the macromolecular complex of granzyme B with serglycin. J Biol Chem. 277:2002;49523-49530.
11. Trapani J.A., Sutton V.R., Thia K.Y., Li Y.Q., Froelich C.J., Jans D.A., Sandrin M.S., Browne K.A. A clathrin/dynamin- and mannose-6-phosphate receptor-independent pathway for granzyme B-induced cell death. J Cell Biol. 160:2003;223-233 Granzyme B enters cells through two independent endocytic mechanisms, one requiring cell-surface receptor binding and the second occurring through constitutive fluid phase uptake. In the absence of receptor-mediated uptake, fluid phase uptake can still efficiently deliver granzyme B for the purposes of apoptosis induction.
12. Alimonti J.B., Shi L., Baijal P.K., Greenberg A.H. Granzyme B induces BID-mediated cytochrome c release and mitochondrial permeability transition. J Biol Chem. 276:2001;6974-6982.
13. Heibein J.A., Goping I.S., Barry M., Pinkoski M.J., Shore G.C., Green D.R., Bleackley R.C. Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members bid and Bax. J Exp Med. 192:2000;1391-1402.
14. Sutton V.R., Davis J.E., Cancilla M., Johnstone R.W., Ruefli A.A., Sedelies K., Browne K.A., Trapani J.A. Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation. J Exp Med. 192:2000;1403-1414.
15. Barry M., Heibein J.A., Pinkoski M.J., Lee S.F., Moyer R.W., Green D.R., Bleackley R.C. Granzyme B short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving Bid. Mol Cell Biol. 20:2000;3781-3794.
16. Metkar S.S., Wang B., Ebbs M.L., Kim J.H., Lee Y.J., Raja S.M., Froelich C.J. Granzyme B activates procaspase-3 which signals a mitochondrial amplification loop for maximal apoptosis. J Cell Biol. 160:2003;875-885.
17. Mullbacher A., Waring P., Tha Hla R., Tran T., Chin S., Stehle T., Museteanu C., Simon M.M. Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. Proc Natl Acad Sci USA. 96:1999;13950-13955.
18. Stepp S.E., Dufourcq-Lagelouse R., Le Deist F., Bhawan S., Certain S., Mathew P.A., Henter J.I., Bennett M., Fischer A., de Saint Basile G.et al. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science. 286:1999;1957-1959.
19. Ericson K.G., Fadeel B., Andersson M., Gudmundsson G.H., Gurgey A., Yalman N., Janka G., Nordenskjold M., Henter J.I. Sequence analysis of the granulysin and granzyme B genes in familial hemophagocytic lymphohistiocytosis. Hum Genet. 112:2003;98-99.
20. McIlroy D., Cartron P.F., Tuffery P., Dudoit Y., Samri A., Autran B., Vallette F.M., Debre P., Theodorou I. A triple-mutated allele of granzyme B incapable of inducing apoptosis. Proc Natl Acad Sci USA. 100:2003;2562-2567 The authors describe a prevalent mutated allele of human granzyme B, and make the case for a defective role in apoptosis induction.
21. Browne K.A., Blink E., Sutton V.R., Froelich C.J., Jans D.A., Trapani J.A. Cytosolic delivery of granzyme B by bacterial toxins: evidence that endosomal disruption, in addition to transmembrane pore formation, is an important function of perforin. Mol Cell Biol. 19:1999;8604-8615.
22. Froelich C.J., Orth K., Turbov J., Seth P., Gottlieb R., Babior B., Shah G.M., Bleackley R.C., Dixit V.M., Hanna W. New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis. J Biol Chem. 271:1996;29073-29079.
23. Shi L., Mai S., Israels S., Browne K., Trapani J.A., Greenberg A.H. Granzyme B (GraB) autonomously crosses the cell membrane and perforin initiates apoptosis and GraB nuclear localization. J Exp Med. 185:1997;855-866.
24. Griffiths G.M. Endocytosing the death sentence. J Cell Biol. 160:2003;155-156.
25. Motyka B., Korbutt G., Pinkoski M.J., Heibein J.A., Caputo A., Hobman M., Barry M., Shostak I., Sawchuk T., Holmes C.F.et al. Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis. Cell. 103:2000;491-500.
26. Griffiths G.M., Isaaz S. Granzymes A and B are targeted to the lytic granules of lymphocytes by the mannose-6-phosphate receptor. J Cell Biol. 120:1993;885-896.
27. Russell J.H., Ley T.J. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol. 20:2002;323-370.
28. Oka Y., Czech M.P. The type II insulin-like growth factor receptor is internalized and recycles in the absence of ligand. J Biol Chem. 261:1986;9090-9093.
29. Blanchard F., Raher S., Duplomb L., Vusio P., Pitard V., Taupin J.L., Moreau J.F., Hoflack B., Minvielle S., Jacques Y.et al. The mannose 6-phosphate/insulin-like growth factor II receptor is a nanomolar affinity receptor for glycosylated human leukemia inhibitory factor. J Biol Chem. 273:1998;20886-20893.
30. Kovacina K.S., Steele-Perkins G., Purchio A.F., Lioubin M., Miyazono K., Heldin C.H., Roth R.A. Interactions of recombinant and platelet transforming growth factor-beta 1 precursor with the insulin-like growth factor II/mannose 6-phosphate receptor. Biochem Biophys Res Commun. 160:1989;393-403.
31. Sharif-Askari E., Alam A., Rheaume E., Beresford P.J., Scotto C., Sharma K., Lee D., DeWolf W.E., Nuttall M.E., Lieberman J.et al. Direct cleavage of the human DNA fragmentation factor-45 by granzyme B induces caspase-activated DNase release and DNA fragmentation. EMBO J. 20:2001;3101-3113.
32. Thomas D.A., Du C., Xu M., Wang X., Ley T.J. DFF45/ICAD can be directly processed by granzyme B during the induction of apoptosis. Immunity. 12:2000;621-632.
33. Wolf B.B., Schuler M., Echeverri F., Green D.R. Caspase-3 is the primary activator of apoptotic DNA fragmentation via DNA fragmentation factor-45/inhibitor of caspase-activated DNase inactivation. J Biol Chem. 274:1999;30651-30656.
34. Zhang D., Beresford P.J., Greenberg A.H., Lieberman J. Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis. Proc Natl Acad Sci USA. 98:2001;5746-5751.
35. Browne K.A., Johnstone R.W., Jans D.A., Trapani J.A. Filamin (280-kDa actin-binding protein) is a caspase substrate and is also cleaved directly by the cytotoxic T lymphocyte protease granzyme B during apoptosis. J Biol Chem. 275:2000;39262-39266.
36. Harris J.L., Peterson E.P., Hudig D., Thornberry N.A., Craik C.S. Definition and redesign of the extended substrate specificity of granzyme B. J Biol Chem. 273:1998;27364-27373.
37. Sutton V.R., Vaux D.L., Trapani J.A. Bcl-2 prevents apoptosis induced by perforin and granzyme B, but not that mediated by whole cytotoxic lymphocytes. J Immunol. 158:1997;5783-5790.
38. Davis J.E., Sutton V.R., Smyth M.J., Trapani J.A. Dependence of granzyme B-mediated cell death on a pathway regulated by Bcl-2 or its viral homolog, BHRF1. Cell Death Differ. 7:2000;973-983.
39. MacDonald G., Shi L., Vande Velde C., Lieberman J., Greenberg A.H. Mitochondria-dependent and -independent regulation of Granzyme B-induced apoptosis. J Exp Med. 189:1999;131-144.
40. Heibein J.A., Barry M., Motyka B., Bleackley R.C. Granzyme B-induced loss of mitochondrial inner membrane potential (Delta Psi m) and cytochrome c release are caspase independent. J Immunol. 163:1999;4683-4693.
41. Coultas L., Huang D.C., Adams J.M., Strasser A. Pro-apoptotic BH3-only Bcl-2 family members in vertebrate model organisms suitable for genetic experimentation. Cell Death Differ. 9:2002;1163-1166.
42. Pinkoski M.J., Waterhouse N.J., Heibein J.A., Wolf B.B., Kuwana T., Goldstein J.C., Newmeyer D.D., Bleackley R.C., Green D.R. Granzyme B-mediated apoptosis proceeds predominantly through a Bcl-2-inhibitable mitochondrial pathway. J Biol Chem. 276:2001;12060-12067.
43. Sutton V.R., Wowk M.E., Cancilla M., Trapani J.A. Caspase activation by granzyme B is indirect, and caspase autoprocessing requires the release of proapoptotic mitochondrial factors. Immunity. 18:2003;319-329 This paper defines the downstream events in caspase activation in response granzyme B. The authors identify several pro-apoptotic factors released from mitochondria that are crucial for displacing IAPs from partly processed caspases. This enables caspase activity to reach lethal threshold in targeted cells.
44. Sarin A., Williams M.S., Alexander-Miller M.A., Berzofsky J.A., Zacharchuk C.M., Henkart P.A. Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Immunity. 6:1997;209-215.
45. Goping I.S., Barry M., Liston P., Sawchuk T., Constantinescu G., Michalak K.M., Shostak I., Roberts D.L., Hunter A.M., Korneluk R.et al. Granzyme B-induced apoptosis requires both direct caspase activation and relief of caspase inhibition. Immunity. 18:2003;355-365.
46. Thomas D.A., Scorrano L., Putcha G.V., Korsmeyer S.J., Ley T.J. Granzyme B can cause mitochondrial depolarization and cell death in the absence of BID, BAX, and BAK. Proc Natl Acad Sci USA. 98:2001;14985-14990.
47. Wei M.C., Zong W.X., Cheng E.H., Lindsten T., Panoutsakopoulou V., Ross A.J., Roth K.A., MacGregor G.R., Thompson C.B., Korsmeyer S.J. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 292:2001;727-730.
48. Wei M.C., Lindsten T., Mootha V.K., Weiler S., Gross A., Ashiya M., Thompson C.B., Korsmeyer S.J. tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14:2000;2060-2071.
49. Eskes R., Desagher S., Antonsson B., Martinou J.C. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol Cell Biol. 20:2000;929-935.
50. Wang G.Q., Wieckowski E., Goldstein L.A., Gastman B.R., Rabinovitz A., Gambotto A., Li S., Fang B., Yin X.M., Rabinowich H. Resistance to granzyme B-mediated cytochrome c release in Bak-deficient cells. J Exp Med. 194:2001;1325-1337.
51. Riera L., Gariglio M., Valente G., Mullbacher A., Museteanu C., Landolfo S., Simon M.M. Murine cytomegalovirus replication in salivary glands is controlled by both perforin and granzymes during acute infection. Eur J Immunol. 30:2000;1350-1355.
52. Balkow S., Kersten A., Tran T.T., Stehle T., Grosse P., Museteanu C., Utermohlen O., Pircher H., von Weizsacker F., Wallich R.et al. Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection. J Virol. 75:2001;8781-8791.
53. Zajac A.J., Dye J.M., Quinn D.G. Control of lymphocytic choriomeningitis virus infection in granzyme B deficient mice. Virology. 305:2003;1-9.
54. Muller U., Sobek V., Balkow S., Holscher C., Mullbacher A., Museteanu C., Mossmann H., Simon M.M. Concerted action of perforin and granzymes is critical for the elimination of Trypanosoma cruzi from mouse tissues, but prevention of early host death is in addition dependent on the FasL/Fas pathway. Eur J Immunol. 33:2003;70-78 This paper describes the fact that granzyme A and B protect against fatal infection with a highly pathogenic strain of Trypanosoma cruzi.
55. Mullbacher A., Wallich R., Moyer R.W., Simon M.M. Poxvirus-encoded serpins do not prevent cytolytic T cell-mediated recovery from primary infections. J Immunol. 162:1999;7315-7321.
56. Jerome K.R., Chen Z., Lang R., Torres M.R., Hofmeister J., Smith S., Fox R., Froelich C.J., Corey L. HSV and glycoprotein J inhibit caspase activation and apoptosis induced by granzyme B or Fas. J Immunol. 167:2001;3928-3935.
57. Waugh S.M., Harris J.L., Fletterick R., Craik C.S. The structure of the pro-apoptotic protease granzyme B reveals the molecular determinants of its specificity. Nat Struct Biol. 7:2000;762-765.
58. Sun J., Whisstock J.C., Harriott P., Walker B., Novak A., Thompson P.E., Smith A.I., Bird P.I. Importance of the P4′ residue in human granzyme B inhibitors and substrates revealed by scanning mutagenesis of the proteinase inhibitor 9 reactive center loop. J Biol Chem. 276:2001;15177-15184.
59. Sun J., Bird C.H., Sutton V., McDonald L., Coughlin P.B., De Jong T.A., Trapani J.A., Bird P.I. A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J Biol Chem. 271:1996;27802-27809.
60. Bird C.H., Sutton V.R., Sun J., Hirst C.E., Novak A., Kumar S., Trapani J.A., Bird P.I. Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Mol Cell Biol. 18:1998;6387-6398.
61. Hirst C.E., Buzza M.S., Bird C.H., Warren H.S., Cameron P.U., Zhang M., Ashton-Rickardt P.G., Bird P.I. The intracellular granzyme B inhibitor, proteinase inhibitor 9, is up-regulated during accessory cell maturation and effector cell degranulation, and its overexpression enhances CTL potency. J Immunol. 170:2003;805-815.
62. Bladergroen B.A., Strik M.C., Bovenschen N., van Berkum O., Scheffer G.L., Meijer C.J., Hack C.E., Kummer J.A. The granzyme B inhibitor, protease inhibitor 9, is mainly expressed by dendritic cells and at immune-privileged sites. J Immunol. 166:2001;3218-3225.
63. Medema J.P., Schuurhuis D.H., Rea D., van Tongeren J., de Jong J., Bres S.A., Laban S., Toes R.E., Toebes M., Schumacher T.N.et al. Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: differential modulation by T helper type 1 and type 2 cells. J Exp Med. 194:2001;657-667.
64. Buzza M.S., Hirst C.E., Bird C.H., Hosking P., McKendrick J., Bird P.I. The granzyme B inhibitor, PI-9, is present in endothelial and mesothelial cells, suggesting that it protects bystander cells during immune responses. Cell Immunol. 210:2001;21-29.
65. Young J.L., Sukhova G.K., Foster D., Kisiel W., Libby P., Schonbeck U. The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cells. J Exp Med. 191:2000;1535-1544.
66. Casciola-Rosen L., Andrade F., Ulanet D., Wong W.B., Rosen A. Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med. 190:1999;815-826.
67. Mahoney J.A., Odin J.A., White S.M., Shaffer D., Koff A., Casciola-Rosen L., Rosen A. The human homologue of the yeast polyubiquitination factor Ufd2p is cleaved by caspase 6 and granzyme B during apoptosis. Biochem J. 361:2002;587-595.
68. Tak P.P., Spaeny-Dekking L., Kraan M.C., Breedveld F.C., Froelich C.J., Hack C.E. The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA). Clin Exp Immunol. 116:1999;366-370.
69. Spaeny-Dekking E.H., Hanna W.L., Wolbink A.M., Wever P.C., Kummer A.J., Swaak A.J., Middeldorp J.M., Huisman H.G., Froelich C.J., Hack C.E. Extracellular granzymes A and B in humans: detection of native species during CTL responses in vitro and in vivo. J Immunol. 160:1998;3610-3616.
70. Lauw F.N., Simpson A.J., Hack C.E., Prins J.M., Wolbink A.M., van Deventer S.J., Chaowagul W., White N.J., van Der Poll T. Soluble granzymes are released during human endotoxemia and in patients with severe infection due to gram-negative bacteria. J Infect Dis. 182:2000;206-213.
71. Shresta S., Graubert T.A., Thomas D.A., Raptis S.Z., Ley T.J. Granzyme A initiates an alternative pathway for granule-mediated apoptosis. Immunity. 10:1999;595-605.
72. Street S.E., Trapani J.A., MacGregor D., Smyth M.J. Suppression of lymphoma and epithelial malignancies effected by interferon gamma. J Exp Med. 196:2002;129-134.
73. Smyth M.J., Street S.E.A., Trapani J.A. Granzymes A and B are not essential for rejection of cancer. J Immunol. 171:2003;515-518.
74. Davis J.E., Smyth M.J., Trapani J.A. Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity. Eur J Immunol. 31:2001;39-47.
75. Pardo J., Balkow S., Anel A., Simon M.M. Granzymes are essential for natural killer cell-mediated and perf-facilitated tumor control. Eur J Immunol. 32:2002;2881-2887.
76. Medema J.P., de Jong J., Peltenburg L.T., Verdegaal E.M., Gorter A., Bres S.A., Franken K.L., Hahne M., Albar J.P., Melief C.J.et al. Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors. Proc Natl Acad Sci USA. 98:2001;11515-11520.
77. Bladergroen B.A., Meijer C.J., ten Berge R.L., Hack C.E., Muris J.J., Dukers D.F., Chott A., Kazama Y., Oudejans J.J., van Berkum O.et al. Expression of the granzyme B inhibitor, protease inhibitor 9, by tumor cells in patients with non-Hodgkin and Hodgkin lymphoma: a novel protective mechanism for tumor cells to circumvent the immune system? Blood. 99:2002;232-237.
78. Ronday H.K., van der Laan W.H., Tak P.P., de Roos J.A., Bank R.A., TeKoppele J.M., Froelich C.J., Hack C.E., Hogendoorn P.C., Breedveld F.C.et al. Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritis. Rheumatology (Oxford). 40:2001;55-61.
79. Gahring L., Carlson N.G., Meyer E.L., Rogers S.W. Granzyme B proteolysis of a neuronal glutamate receptor generates an autoantigen and is modulated by glycosylation. J Immunol. 166:2001;1433-1438.
80. Andrade F., Roy S., Nicholson D., Thornberry N., Rosen A., Casciola-Rosen L. Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity. 8:1998;451-460.
81. Froelich C.J., Hanna W.L., Poirier G.G., Duriez P.J., D'Amours D., Salvesen G.S., Alnemri E.S., Earnshaw W.C., Shah G.M. Granzyme B/perforin-mediated apoptosis of Jurkat cells results in cleavage of poly(ADP-ribose) polymerase to the 89-kDa apoptotic fragment and less abundant 64-kDa fragment. Biochem Biophys Res Commun. 227:1996;658-665.
82. Germain M., Affar E.B., D'Amours D., Dixit V.M., Salvesen G.S., Poirier G.G. Cleavage of automodified poly(ADP-ribose) polymerase during apoptosis. Evidence for involvement of caspase-7. J Biol Chem. 274:1999;28379-28384.
83. Wieckowski E., Wang G.Q., Gastman B.R., Goldstein L.A., Rabinowich H. Granzyme B-mediated degradation of T-cell receptor zeta chain. Cancer Res. 62:2002;4884-4889.
84. Li H., Zhu H., Xu C.J., Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:1998;491-501.
85. Darmon A.J., Nicholson D.W., Bleackley R.C. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature. 377:1995;446-448.
86. Kam C.M., Hudig D., Powers J.C. Granzymes (lymphocyte serine proteases): characterization with natural and synthetic substrates and inhibitors. Biochim Biophys Acta. 1477:2000;307-323.
87. Stennicke H.R., Jurgensmeier J.M., Shin H., Deveraux Q., Wolf B.B., Yang X., Zhou Q., Ellerby H.M., Ellerby L.M., Bredesen D.et al. Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem. 273:1998;27084-27090.
88. Stennicke H.R., Salvesen G.S. Catalytic properties of the caspases. Cell Death Differ. 6:1999;1054-1059.
89. Stennicke H.R., Salvesen G.S. Caspases - controlling intracellular signals by protease zymogen activation. Biochim Biophys Acta. 1477:2000;299-306.